• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类表皮生长受体多态性(-rs11543848和-rs1136201)在巴基斯坦开伯尔-普赫图赫瓦省的普什图族人群中与乳腺癌风险呈现出显著关联。

Human epidermal growth receptor polymorphisms (-rs11543848 and -rs1136201) exhibited significant association with breast cancer risk in Pashtun population of Khyber Pakhtunkhwa, Pakistan.

作者信息

Sombal Wafa, Khan Najeeb Ullah, Khan Bibi Maryam, Ismail Muhammad, Almutairi Mikhlid H, Khan Samiullah, Khan Aakif Ullah, Mustafa Adeela, Iftikhar Bushra, Ali Ijaz

机构信息

Institute of Biotechnology & Genetic Engineering (Health Division) The University of Agriculture Peshawar Peshawar Pakistan.

School of Life Science Jiangsu University Zhejiang Jiangsu Province People's Republic of China.

出版信息

Health Sci Rep. 2024 Feb 4;7(2):e1846. doi: 10.1002/hsr2.1846. eCollection 2024 Feb.

DOI:10.1002/hsr2.1846
PMID:38317673
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10839356/
Abstract

BACKGROUND AND AIMS

Breast cancer is the most common type of cancer in women. The genetic polymorphism in HER (-rs11543848 and -rs1136201) were found to be associated with breast cancer risk in different ethnicities worldwide with inconsistent results. The aim of this research study was to evaluate the association of -rs11543848 and -rs1136201 polymorphisms as a risk of breast cancer in Pashtun population of Khyber Pakhtunkhwa, Pakistan.

METHODS

A total of 314 women including 164 breast cancer patients and 150 age and gender-matched healthy controls were enrolled from June 2021 to May 2022. All the samples were subjected to DNA extraction followed by Tetra-ARMS-PCR for genotyping and gel electrophoresis.

RESULTS

Our results indicated that -rs11543848 risk allele A ( = 0.0001) and heterozygous genotype GA ( = 0.0001) displayed highly significant association with breast cancer, while the homozygous mutant genotype AA indicated association but nonsignificant results (odds ratio [OR] = 2.637, 95% confidence interval [CI] = 1.2258-5.6756,  = 0.0833). Similarly, the -rs1136201 risk allele G ( = 0.0023), the heterozygous genotype AG ( = 0.0530) and homozygous mutant genotype GG showed significant association (OR = 2.5946, 95% CI = 0.9876-6.8165,  = 0.0530) with breast cancer risk. Both the SNPs presented a higher but nonsignificant risk of breast cancer in postmenopausal women (OR = 2.242,  = 0.08 and OR = 2.009,  = 0.06). However, both the SNPs showed significant association ( < 0.005) with family history, metastasis, stage, luminal B, and TNBC.

CONCLUSION

In conclusion, -rs11543848 and -rs1136201 polymorphisms are significantly associated with the higher risk of breast cancer in Pashtun population of Khyber Pakhtunkhwa, Pakistan. These findings advocate for further exploration with larger datasets, offering promising avenues for personalized approaches in breast cancer research and potentially enhancing clinical practices for better risk assessment and targeted management strategies.

摘要

背景与目的

乳腺癌是女性中最常见的癌症类型。已发现HER基因的多态性(-rs11543848和-rs1136201)与全球不同种族的乳腺癌风险相关,但结果不一致。本研究的目的是评估-rs11543848和-rs1136201多态性作为巴基斯坦开伯尔-普赫图赫瓦省普什图族人群患乳腺癌风险的相关性。

方法

2021年6月至2022年5月,共招募了314名女性,其中包括164名乳腺癌患者和150名年龄及性别匹配的健康对照。所有样本均进行DNA提取,然后采用四引物扩增受阻突变系统聚合酶链反应(Tetra-ARMS-PCR)进行基因分型和凝胶电泳。

结果

我们的结果表明,-rs11543848风险等位基因A(P = 0.0001)和杂合基因型GA(P = 0.0001)与乳腺癌呈高度显著相关性,而纯合突变基因型AA显示出相关性但结果不显著(优势比[OR] = 2.637,95%置信区间[CI] = 1.2258 - 5.6756,P = 0.0833)。同样,-rs1136201风险等位基因G(P = 0.0023)、杂合基因型AG(P = 0.0530)和纯合突变基因型GG与乳腺癌风险呈显著相关性(OR = 2.5946,95% CI = 0.9876 - 6.8165,P = 0.0530)。这两个单核苷酸多态性(SNP)在绝经后女性中均呈现出较高但不显著的乳腺癌风险(OR = 2.242,P = 0.08和OR = 2.009,P = 0.06)。然而,这两个SNP与家族史、转移、分期、管腔B型和三阴性乳腺癌(TNBC)均显示出显著相关性(P < 0.005)。

结论

总之,-rs11543848和-rs1136201多态性与巴基斯坦开伯尔-普赫图赫瓦省普什图族人群患乳腺癌的较高风险显著相关。这些发现主张使用更大的数据集进行进一步探索,为乳腺癌研究中的个性化方法提供了有前景的途径,并可能改善临床实践以实现更好的风险评估和靶向管理策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/723f/10839356/2ef4cdcf3cb5/HSR2-7-e1846-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/723f/10839356/2ef4cdcf3cb5/HSR2-7-e1846-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/723f/10839356/2ef4cdcf3cb5/HSR2-7-e1846-g001.jpg

相似文献

1
Human epidermal growth receptor polymorphisms (-rs11543848 and -rs1136201) exhibited significant association with breast cancer risk in Pashtun population of Khyber Pakhtunkhwa, Pakistan.人类表皮生长受体多态性(-rs11543848和-rs1136201)在巴基斯坦开伯尔-普赫图赫瓦省的普什图族人群中与乳腺癌风险呈现出显著关联。
Health Sci Rep. 2024 Feb 4;7(2):e1846. doi: 10.1002/hsr2.1846. eCollection 2024 Feb.
2
Assessment of HER1 (rs11543848) and HER2 (rs1136201) polymorphism and their association with colorectal cancer susceptibility in Khyber Pakhtunkhwa, Pakistan.评估 HER1(rs11543848)和 HER2(rs1136201)多态性及其与巴基斯坦开伯尔-普赫图赫瓦省结直肠癌易感性的关系。
Mol Biol Rep. 2023 Dec 1;51(1):1. doi: 10.1007/s11033-023-08943-y.
3
Preliminary investigation of MMP8 (rs11225395) and MMP9 (rs3787268) polymorphisms association with breast cancer risk in pashtun women of Pakistan.基质金属蛋白酶 8(rs11225395)和基质金属蛋白酶 9(rs3787268)多态性与巴基斯坦普什图妇女乳腺癌风险的初步研究。
Mol Biol Rep. 2024 Oct 3;51(1):1034. doi: 10.1007/s11033-024-09968-7.
4
Significant association of BRCA1 (rs1799950), BRCA2 (rs144848) and TP53 (rs1042522) polymorphism with breast cancer risk in Pashtun population of Khyber Pakhtunkhwa, Pakistan.BRCA1(rs1799950)、BRCA2(rs144848)和 TP53(rs1042522)多态性与巴基斯坦开伯尔-普赫图赫瓦省帕坦族乳腺癌风险的显著关联。
Mol Biol Rep. 2023 Jul;50(7):6087-6096. doi: 10.1007/s11033-023-08463-9. Epub 2023 Jun 10.
5
Risk association of RANKL and OPG gene polymorphism with breast cancer to bone metastasis in Pashtun population of Khyber Pakhtunkhwa, Pakistan.巴基斯坦开伯尔-普赫图赫瓦省帕坦族群中 RANKL 和 OPG 基因多态性与乳腺癌骨转移的风险关联。
PLoS One. 2022 Nov 8;17(11):e0276813. doi: 10.1371/journal.pone.0276813. eCollection 2022.
6
Association analysis of miRNA-146a and miRNA-196a polymorphism with breast cancer risk in Khyber Pakhtunkhwa, Pakistan: a preliminary study.miRNA-146a 和 miRNA-196a 多态性与巴基斯坦开伯尔-普赫图赫瓦乳腺癌风险的关联分析:一项初步研究。
Mol Biol Rep. 2024 Jul 20;51(1):827. doi: 10.1007/s11033-024-09765-2.
7
Estrogen receptor alpha (ESR1) gene polymorphism (rs2234693 and rs2046210) with breast cancer risk in pashtun population of Khyber Pakhtunkhwa.雌激素受体 alpha(ESR1)基因多态性(rs2234693 和 rs2046210)与开伯尔-普赫图赫瓦省普什图族人群的乳腺癌风险相关。
Mol Biol Rep. 2023 Mar;50(3):2445-2451. doi: 10.1007/s11033-022-08198-z. Epub 2023 Jan 3.
8
Association of and genes polymorphisms with familial breast cancer in patients of Khyber Pakhtunkhwa, Pakistan.与家族性乳腺癌相关的 和 基因多态性在巴基斯坦开伯尔-普赫图赫瓦省患者中的研究。
Afr Health Sci. 2022 Sep;22(3):145-154. doi: 10.4314/ahs.v22i3.17.
9
Association between Aldosterone Synthase () Gene Polymorphism and Hypertension in Pashtun Ethnic Population of Khyber Pakhtunkwha, Pakistan.醛固酮合酶()基因多态性与巴基斯坦开伯尔-普赫图赫瓦省帕坦族裔人群高血压的关联。
Genes (Basel). 2023 May 29;14(6):1184. doi: 10.3390/genes14061184.
10
Association of nasopharyngeal cancer risk with genetic polymorphisms of drug-metabolizing enzyme genes GSTM1, GSTT1 and CYP1A1 (rs4646903 variant), in tobacco addicted patients of Pashtun ethnicity of Khyber Pakhtunkhwa Province of Pakistan.巴基斯坦开伯尔-普赫图赫瓦省普什图族烟草成瘾患者中,鼻咽癌风险与药物代谢酶基因GSTM1、GSTT1和CYP1A1(rs4646903变异体)基因多态性的关联。
Pak J Pharm Sci. 2019 Sep;32(5):2107-2116.

引用本文的文献

1
Association of ESR1, HER1, and HER2 Polymorphisms with Breast Cancer Risk in the KP Population, A Case-Control Study.一项病例对照研究:KP人群中ESR1、HER1和HER2基因多态性与乳腺癌风险的关联
J Mammary Gland Biol Neoplasia. 2025 Mar 27;30(1):6. doi: 10.1007/s10911-025-09581-9.

本文引用的文献

1
HER2 Signaling and Breast Cancer Stem Cells: The Bridge behind HER2-Positive Breast Cancer Aggressiveness and Therapy Refractoriness.HER2信号传导与乳腺癌干细胞:HER2阳性乳腺癌侵袭性和治疗难治性背后的桥梁
Cancers (Basel). 2021 Sep 24;13(19):4778. doi: 10.3390/cancers13194778.
2
Epidermal growth factor receptor inhibitors as potential anticancer agents: An update of recent progress.表皮生长因子受体抑制剂作为潜在的抗癌药物:最新进展综述。
Bioorg Chem. 2021 Nov;116:105393. doi: 10.1016/j.bioorg.2021.105393. Epub 2021 Oct 2.
3
EGFR in Cancer: Signaling Mechanisms, Drugs, and Acquired Resistance.
癌症中的表皮生长因子受体(EGFR):信号传导机制、药物及获得性耐药
Cancers (Basel). 2021 Jun 1;13(11):2748. doi: 10.3390/cancers13112748.
4
Global Perceptions of Women on Breast Cancer and Barriers to Screening.全球女性对乳腺癌的认知及筛查障碍
Curr Oncol Rep. 2021 May 3;23(7):74. doi: 10.1007/s11912-021-01069-z.
5
Better Reporting and Awareness Campaigns Needed for Breast Cancer in Pakistani Women.巴基斯坦女性乳腺癌需要更好的报告和宣传活动。
Cancer Manag Res. 2021 Mar 2;13:2125-2129. doi: 10.2147/CMAR.S270671. eCollection 2021.
6
The Latest Battles Between EGFR Monoclonal Antibodies and Resistant Tumor Cells.表皮生长因子受体单克隆抗体与耐药肿瘤细胞之间的最新较量
Front Oncol. 2020 Jul 24;10:1249. doi: 10.3389/fonc.2020.01249. eCollection 2020.
7
Determination of mutations in iron regulating genes of beta thalassemia major patients of Khyber Pakhtunkhwa, Pakistan.巴基斯坦开伯尔-普赫图赫瓦省重型β地中海贫血患者铁调节基因中的突变测定
Mol Genet Genomic Med. 2020 Sep;8(9):e1310. doi: 10.1002/mgg3.1310. Epub 2020 Jun 25.
8
Interleukin-6 polymorphisms in HCC patients chronically infected with HCV.慢性丙型肝炎病毒感染的肝癌患者白细胞介素-6基因多态性
Infect Agent Cancer. 2020 Apr 1;15:21. doi: 10.1186/s13027-020-00285-9. eCollection 2020.
9
Review on Epidermal Growth Factor Receptor (EGFR) Structure, Signaling Pathways, Interactions, and Recent Updates of EGFR Inhibitors.表皮生长因子受体 (EGFR) 的结构、信号通路、相互作用综述及 EGFR 抑制剂的最新进展。
Curr Top Med Chem. 2020;20(10):815-834. doi: 10.2174/1568026620666200303123102.
10
Molecular Targeting Therapy against EGFR Family in Breast Cancer: Progress and Future Potentials.乳腺癌中针对表皮生长因子受体(EGFR)家族的分子靶向治疗:进展与未来潜力
Cancers (Basel). 2019 Nov 20;11(12):1826. doi: 10.3390/cancers11121826.